| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 04/15/2009 | EP2046819A2 Methods of increasing secretion of polypeptides having biological activity |
| 04/15/2009 | EP2046384A2 Antibodies blocking fibroblast growth factor receptor activation and methods of use thereof |
| 04/15/2009 | EP1937826B1 Enzymatic conversion of oligopeptide amides to oligopeptide alkyl esters |
| 04/15/2009 | EP1710250B1 Method for preparing human serum albumin through heat-treatment in presence of divalent cation |
| 04/15/2009 | EP1505148B1 Methods of screening for agonistic antibodies |
| 04/15/2009 | EP1390490B1 Muscle-specific expression vectors |
| 04/15/2009 | EP1352085B1 P2y purinergic receptor expression for identifying preneoplastic and neoplastic states |
| 04/15/2009 | EP1257295B1 Factor vii or viia-like molecules |
| 04/15/2009 | EP0792292B2 Estrogen receptor |
| 04/15/2009 | CN101410529A Method for producing an interleukin-2 preparation and the thus obtainable preparation |
| 04/15/2009 | CN101410528A Methods for modulating mannose content of recombinant proteins |
| 04/15/2009 | CN101410517A Polynucleotide for producing recombinant protein in silkworm |
| 04/15/2009 | CN101407834A Method for preparing collagen peptide by using cod skin |
| 04/15/2009 | CN101407832A Method for producing chitin, calcium citrate and protein powder |
| 04/15/2009 | CN101407768A Saccharomyces cerevisiae mutant bacterial strain and use thereof in glutathion production by fermentation |
| 04/15/2009 | CN100478689C Polypeptide and use thereof |
| 04/15/2009 | CN100478450C Method for hydrolyzing, separating and preparing rice starch and rice peptide using enzyme method |
| 04/15/2009 | CN100478444C Biological production of acetic acid from waste gases |
| 04/15/2009 | CN100478355C New human protein with mouse NIH/3T3 cell transformation improving function and its code sequence |
| 04/15/2009 | CN100478354C Novel human protein with cancer inhibiting function and its code sequence |
| 04/15/2009 | CN100478029C Immunomodulatory human MHC class II antigen-binding polypeptides |
| 04/14/2009 | US7517976 proteins and/or polypeptides encoded by DNA isolated from rna viruses, used as vaccines, for detection and treatment of swine infected with PRRSV |
| 04/14/2009 | US7517974 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders |
| 04/14/2009 | US7517971 Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity |
| 04/14/2009 | US7517970 Using transgenic cells comprising nucleotide sequences coding tyrosine kinase/phosphatase fusion as tool indentifying enzyme inhibitors; drug screening; mimetics |
| 04/14/2009 | US7517967 Monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma |
| 04/14/2009 | US7517966 antibodies that bind polypeptides that are prefrentially expressed by all mature NK cells, used for medical diagnosis, prevention of viral and microbial infections, and as antitumor agents |
| 04/14/2009 | US7517964 RS7 antibodies |
| 04/14/2009 | US7517962 TWEAK receptor |
| 04/14/2009 | US7517961 Homogeneous preparations of IL-28 and IL-29 |
| 04/14/2009 | US7517960 comprising polypeptides, fusion proteins, dimers and tetramers, useful for identification and development of activators and inhibitors for treating nervous system disorders |
| 04/14/2009 | US7517949 Livin-derived peptides, compositions and uses thereof |
| 04/14/2009 | US7517866 LIM mineralization protein splice variants |
| 04/14/2009 | US7517684 Nucleic acid and amino acid sequences relating to Pseudomonas aeruginosa for diagnostics and therapeutics |
| 04/14/2009 | US7517678 culturing host cells that have been tranfected with a transaminase gene comprising dna sequences that code for a polypeptide having tranferase enzyme activity |
| 04/14/2009 | US7517677 a polypeptide having a higher catalytic activity for oxidation of cephalosporin C to glutaryl-7-aminocephalosporanic acid, than that of the wild-type polypeptide |
| 04/14/2009 | US7517676 polynucleotide comprising a DNA sequence that codes for a polypeptide having oxidoreductase enzyme activity, used in detection assays, gene therapy, and screening assays |
| 04/14/2009 | US7517672 Nucleic acids encoding mammalian T-type calcium channels |
| 04/14/2009 | US7517671 Methods and compositions for concentrating secreted recombinant protein |
| 04/14/2009 | US7517670 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 04/14/2009 | US7517669 Increasing the intracellular amount of at least one ferritin-H or a derivative to an effective level for suppressing disease caused or enhanced by effects of intracellular iron mismanagement |
| 04/14/2009 | US7517668 Process for the production of protein products in aspergillus |
| 04/14/2009 | US7517667 Methods for promoting, inhibiting and detecting toxin entry into cells |
| 04/14/2009 | US7517666 Using urease as tool in identifying modulators of bacterial propagation; enzyme inhibitors |
| 04/14/2009 | US7517663 Rabbit monoclonal antibody against Id1 protein |
| 04/14/2009 | US7517658 Drug screening for human SNORF33 receptor agonist by contacting cells transfected with and expressing DNA encoding the human SNORF33 receptor, wherein cells prior to being transfected with the DNA do not express the human SNORF33 receptor; inflammation, infections, arthritis; autoimmune diseases |
| 04/14/2009 | US7517647 Screening retroviral cDNA library to identify transforming growth factor activator for use tool in prevention and treatment of cell proliferative and inflammatory disorders |
| 04/14/2009 | US7517533 Pseudomonas aeruginosa antigens |
| 04/14/2009 | US7517527 Immunotoxin with in vivo T cell suppressant activity and methods of use |
| 04/14/2009 | US7517524 Monoclonal antibody or an antigen-binding fragment thereof which binds to human VEGF-B (vascular endothelial growth factor) produced by hybridoma; neovascularization diseases; antitumor, anticarcinogenic, antiinflammatory, and antimetastasis agents; rheumatoid arthritis; angiogenesis inhibitors |
| 04/14/2009 | US7517523 Anti-MIF antibodies |
| 04/14/2009 | CA2395266C Use of acid-stable subtilisin proteases in animal feed |
| 04/14/2009 | CA2259657C Identification of a transforming fragment of herpes simplex type 2 and detection thereof in clinical specimens |
| 04/14/2009 | CA2201887C Patched genes and their use |
| 04/14/2009 | CA2130900C Therapeutic domains of von willebrand factor |
| 04/09/2009 | WO2009045957A1 Human antibodies that bind mesothelin, and uses thereof |
| 04/09/2009 | WO2009045553A1 High pressure treatment of aggregated interferons |
| 04/09/2009 | WO2009044561A1 ANTI-proNT/NMN MONOCLONAL ANTIBODY |
| 04/09/2009 | WO2009043166A1 An anti-cancer cytotoxic monoclonal antibody |
| 04/09/2009 | WO2009020559A3 Agents that inhibit p-tefb interactions and methods of use thereof |
| 04/09/2009 | WO2008144659A3 Dickkopf-1 (dkk1) as a universal tumor vaccine for immunotherapy of cancers |
| 04/09/2009 | WO2008140478A3 Compositions and methods for immunodominant antigens |
| 04/09/2009 | WO2008127271A3 Interleukin -13 binding proteins |
| 04/09/2009 | WO2008019062A3 Polypeptide derivatives of parathyroid hormone (pth) |
| 04/09/2009 | WO2008008256A3 Methods for enhancing production of isoprenoid compounds by host cells |
| 04/09/2009 | WO2006127040A3 Protein scaffolds and uses therof |
| 04/09/2009 | WO2006101520A3 Fluorescent proteins and related methods and compounds |
| 04/09/2009 | WO2006099569A3 Methods and compositions for beryllium-induced disease |
| 04/09/2009 | WO2006083957A3 Tat-001 and methods of assessing and treating cancer |
| 04/09/2009 | WO2006076024A3 A method for targeting synapse with acetylcholinesterase |
| 04/09/2009 | WO2006055689A3 Protein scaffolds and uses thereof |
| 04/09/2009 | WO2006052871A3 Docosahexaenoic acid producing strains of yarrowia lipolytica |
| 04/09/2009 | WO2006039630A3 Materials and methods for identifying compounds that modulate the cell cycle |
| 04/09/2009 | WO2005113833A3 Polymorphism in tryptophan hydroxylase-2 controls brain serotonin synthesis |
| 04/09/2009 | WO2005112979A3 Methods of preventing and treating alimentary mucositis |
| 04/09/2009 | WO2005108565A3 Modified xylanase, methods of making and use thereof |
| 04/09/2009 | WO2005059099A3 Human ipla2t |
| 04/09/2009 | WO2005047305A3 Cellular membrane protein assay |
| 04/09/2009 | WO2005044979A3 Glycosylation enzymes and systems and methods of making and using them |
| 04/09/2009 | WO2005032496A3 Hydrolases, nucleic acids encoding them and mehods for making and using them |
| 04/09/2009 | WO2005001061A3 Polynucleotides encoding novel adiponectin receptor variants |
| 04/09/2009 | US20090094715 Methods of use of antibodies with reduced immunogenicity or toxicity |
| 04/09/2009 | US20090094714 Novel insecticidal polypeptides of given amino acid sequence obtained by culturing Bacillus thuringiensis; for controlling an insect population, such as Colorado potato beetle, southern corn rootworm and western corn rootworm |
| 04/09/2009 | US20090094708 Vitamin K Epoxide Recycling Polypeptide VKORC1, a Therapeutic Target of Coumarin and Their Derivatives |
| 04/09/2009 | US20090094704 for determining bioactive intact PTH levels in serum, plasma, and/or cell culture media; have a novel recognition for amino acid residues extending beyond the first N-terminal PTH residue; have binding affinity and specificity for PTH that have mitigated cross-reactivity to large non (1-84) PTH fragments |
| 04/09/2009 | US20090093622 BASB029 polynucleotide(s) and polypeptides from Neisseria meningitidis |
| 04/09/2009 | US20090093407 Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |
| 04/09/2009 | US20090093405 Non-Natural Amino Acid Polypeptides Having Modified Immunogenicity |
| 04/09/2009 | US20090093402 Albumin Fusion Proteins |
| 04/09/2009 | US20090093400 Truncated keratinocyte growth factor (KGF) having increased biological activity |
| 04/09/2009 | US20090093057 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 04/09/2009 | US20090093052 Human Hematopoietic Stem And Progenitor Antigen And Methods For Its Use |
| 04/09/2009 | US20090093043 Thermostable nucleic acid polymerase from thermococcus gorgonarius |
| 04/09/2009 | US20090093039 Regulatable growth of filamentous fungi |
| 04/09/2009 | US20090093026 TRANSDUCIBLE DELIVERY OF siRNA BY dsRNA BINDING DOMAIN FUSIONS TO PTD/CPPS |
| 04/09/2009 | US20090093025 Twin-arginine translocation in Bacillus |
| 04/09/2009 | US20090093024 Methods of generating libraries and uses thereof |
| 04/09/2009 | US20090093023 Elements for improved expression of bovine somatotropin |
| 04/09/2009 | US20090093022 Chemosensory gene family encoding gustatory and odorant receptors and uses thereof |
| 04/09/2009 | US20090093021 Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |